OPNT: PD Data for OPNT003 Expected 4Q21…
By David Bautz, PhD
NASDAQ:OPNT
READ THE FULL OPNT RESEARCH REPORT
BIOAF: New Funding & Research Collaborations Expand xB3 Opportunities
By John Vandermosten, CFA
OTC:BIOAF
READ THE FULL BIOAF RESEARCH REPORT
DYAI: C1 Deals Extend Reach to 40% of World
By John Vandermosten, CFA
NASDAQ:DYAI
READ THE FULL DYAI RESEARCH REPORT
ATE.TO: Unexpected Liver Enzyme Elevations Leads to Pause in AME Trial…
By David Bautz, PhD
OTC:ATBPF | TSX:ATE.TO
READ THE FULL ATE.TO RESEARCH REPORT
TSEM: Tower Continues to Grow as it Adds Capacity to Meet Increasing Demand
By Lisa Thompson
NASDAQ:TSEM
READ THE FULL TSEM RESEARCH REPORT
OIIM: O2Micro Q2 Revenues Grow 52% and Are Only Gated By Capacity
By Lisa Thompson
NASDAQ:OIIM
READ THE FULL OIIM RESEARCH REPORT
EEIQ: Growing Enrollments & Diversification Efforts – Positive Indicators
By M. Marin
NASDAQ:EEIQ
READ THE FULL EEIQ RESEARCH REPORT
EEIQ: Growing Enrollments & Diversification Efforts – Positive Indicators
By M. Marin
NASDAQ:EEIQ
READ THE FULL EEIQ RESEARCH REPORT